Literature DB >> 24412076

EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients.

D Domańska-Pakieła1, M Kaczorowska2, E Jurkiewicz3, K Kotulska2, D Dunin-Wąsowicz2, S Jóźwiak2.   

Abstract

Tuberous sclerosis complex (TSC) is a multisystem, autosomal dominant disorder characterized by multiple hamartomas development. Epilepsy is the most common symptom appearing in 80-90% of the patients mainly in the first year of life. A prompt and early seizure control is crucial and can prevent development of an epileptic encephalopathy and secondary mental retardation. Therefore the very early identification of seizures seems to be of a great importance. We present the cases of 5 patients diagnosed with TSC prenatally or perinatally and regularly monitored (at 4-6 weeks intervals) with EEG before the epilepsy onset. The patients' age at baseline varied from 9 days to 9 weeks. In all of the patients epileptiform discharges preceded the epilepsy onset. The time interval between abnormality detection on EEG and the epilepsy onset varied from 1 to 8 days. The patient's age at the epilepsy onset ranged from the 17th day to the 5th month of life. In one patient the EEG was abnormal from the beginning and in this patient the epileptic seizures started from the neonatal period. In the rest of the patients (4/5) the EEG remained normal throughout the first months of life. In all of the children epilepsy started with focal motor seizures. Our study is the first prospective one showing the results of the EEG monitoring in TSC patients and the natural evolution of the EEG patterns in patients with the seizures types other than infantile spasms.
Copyright © 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EEG monitoring; Epilepsy; Epileptiform discharges; TSC

Mesh:

Year:  2013        PMID: 24412076     DOI: 10.1016/j.ejpn.2013.12.006

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  17 in total

Review 1.  The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.

Authors:  Paolo Curatolo; Marit Bjørnvold; Patricia E Dill; José Carlos Ferreira; Martha Feucht; Christoph Hertzberg; Anna Jansen; Sergiusz Jóźwiak; J Christopher Kingswood; Katarzyna Kotulska; Alfons Macaya; Romina Moavero; Rima Nabbout; Bernard A Zonnenberg
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

Review 2.  Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management.

Authors:  Sharon Samueli; Klaus Abraham; Anastasia Dressler; Gudrun Groeppel; Constanze Jonak; Angelika Muehlebner; Daniela Prayer; Andreas Reitner; Martha Feucht
Journal:  Wien Klin Wochenschr       Date:  2015-04-10       Impact factor: 1.704

Review 3.  WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?

Authors:  Sergiusz Jozwiak; Albert Becker; Carlos Cepeda; Jerome Engel; Vadym Gnatkovsky; Gilles Huberfeld; Mehmet Kaya; Katja Kobow; Michele Simonato; Jeffrey A Loeb
Journal:  Epilepsia       Date:  2017-04-07       Impact factor: 5.864

Review 4.  Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism.

Authors:  Peter E Davis; Jurriaan M Peters; Darcy A Krueger; Mustafa Sahin
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

5.  Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.

Authors:  Joyce Y Wu; Jurriaan M Peters; Monisha Goyal; Darcy Krueger; Mustafa Sahin; Hope Northrup; Kit Sing Au; Gary Cutter; E Martina Bebin
Journal:  Pediatr Neurol       Date:  2015-09-25       Impact factor: 3.372

Review 6.  Impact of predictive, preventive and precision medicine strategies in epilepsy.

Authors:  Rima Nabbout; Mathieu Kuchenbuch
Journal:  Nat Rev Neurol       Date:  2020-10-19       Impact factor: 42.937

Review 7.  Autism spectrum disorder and epileptic encephalopathy: common causes, many questions.

Authors:  Siddharth Srivastava; Mustafa Sahin
Journal:  J Neurodev Disord       Date:  2017-06-23       Impact factor: 4.025

Review 8.  Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine.

Authors:  Susanne Schubert-Bast; Adam Strzelczyk
Journal:  Ther Adv Neurol Disord       Date:  2021-07-17       Impact factor: 6.570

9.  Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis.

Authors:  Romina Moavero; Sara Marciano; Federica Graziola; Paolo Curatolo
Journal:  Epilepsy Behav Case Rep       Date:  2016-01-13

10.  Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?

Authors:  Monika Słowińska; Sergiusz Jóźwiak; Angela Peron; Julita Borkowska; Dariusz Chmielewski; Krzysztof Sadowski; Elżbieta Jurkiewicz; Aglaia Vignoli; Francesca La Briola; Maria Paola Canevini; Katarzyna Kotulska-Jóźwiak
Journal:  Orphanet J Rare Dis       Date:  2018-01-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.